| 2nd Challenge: summary of challenges regarding approach individualization |
|---|
| Heterogeneous population |
| Moderate to high risk in the most utilized risk stratification scores (TIMI, GRACE) |
| Treatment should consider overall health, comorbidities, cognitive status, life expectancy, frailty, patient's wishes and preferences |
| It is necessary to pay attention to pharmacokinetic alterations and sensitivity to hypotensive drugs |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.